Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Héctor Spínola-Maroño"'
Publikováno v:
Current Problems in Cancer. 43:324-330
Background and purpose Cancer and stroke are the second and third causes of death worldwide; brain metastases (BM) occur in one third of patients with cancer, any neurologic deficit in these population always prompts the clinician to discard metastas
Autor:
Alberto González-Aguilar, Héctor Spínola-Maroño, Nancy Reynoso, Bernardo Cacho-Díaz, Alejandro Mohar-Betancourt
Publikováno v:
Clinical Breast Cancer. 19:e394-e398
Introduction Breast cancer (BC) is the most common cancer in women, and the incidence of brain metastasis (BM) from BC ranges from 20% to 30%, with a median survival of 10 to 15 months. Previous reports have shown that the presence of obesity or diab
Autor:
Laura G. Mendoza-Olivas, Alejandro Monroy-Sosa, Carlos Cantú-Brito, Karen Salmerón-Moreno, Bernardo Cacho-Díaz, Myrna Candelaria-Hernández, Héctor Spínola-Maroño
Publikováno v:
Revista Mexicana de Neurociencia. 21
Autor:
Laura G. Mendoza-Olivas, Héctor Spínola-Maroño, Víctor A. Arrieta, Talia Wegman-Ostrosky, Martín Granados-García, Bernardo Cacho-Díaz, Mariana Chavez-MacGregor
Publikováno v:
Clinical Neurology and Neurosurgery. 173:61-64
Objectives Breast cancer (BC) is the leading cause of morbidity and mortality. Neurological symptoms are highly feared because they are associated with central nervous system metastases (CNSm). So, we aimed to analyze the association of neurological
Publikováno v:
Journal of Neuro-Oncology. 140:569-574
Cerebrovascular disease (CVD) and cancer are among the most common causes of mortality worldwide, preceded only by ischemic heart disease (IHD). Thrombocytopenia was shown to be associated with poor outcomes in IHD and CVD in the general population.
Autor:
Laura G. Mendoza-Olivas, Héctor Spínola-Maroño, Ytel Jazmin Garcilazo-Reyes, Javier Mexi Yaotzin Prado-Peredo, Bernardo Cacho-Díaz, Myrna Candelaria-Hernández, Karen Salmerón-Moreno
Publikováno v:
Medical Research Archives. 8
This study aims to determine the utility of the neutrophil-to-lymphocyte-ratio (NLR) and platelet-to-lymphocyte-ratio (PLR) as prognostic markers for brain metastasis (BM). Employing NLR cutoff values at BM diagnosis, 550 patients were divided into g
Autor:
Gervith Reyes-Soto, Bernardo Cacho-Díaz, Laura G. Mendoza-Olivas, Héctor Spínola-Maroño, Oscar Arrieta, Alejandro Monroy-Sosa
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 21(11)
Lung cancer (LC) is the most common source of brain metastases (BM). Because of the difficulty in predicting LC patients who will develop BM, we aimed to identify the clinical and serologic markers that could predict the presence of BM in LC patients
INTRODUCTION: Cerebrovascular disease (CVD) and cancer are among the most common causes of mortality worldwide, preceded only by ischemic heart disease (IHD). Thrombocytopenia was shown to be associated with poor outcomes in IHD and CVD in the genera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd1a45696245465de9e879eeeee529ee
https://europepmc.org/articles/PMC6216852/
https://europepmc.org/articles/PMC6216852/
Publikováno v:
Journal of neuro-oncology. 140(1)
Cancer is a leading cause of death worldwide; central nervous system metastases (CNSm) are amongst the most common complications of cancer and are associated with high morbidity and mortality. The aim of the study was to associate clinic and oncologi
Autor:
Bernardo Cacho-Díaz, Nydia A. Lorenzana-Mendoza, Gervith Reyes-Soto, Héctor Spínola-Maroño, Carlos Cantú-Brito
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 27(2)
Purpose The objective of this study was to identify and describe the comorbidities, clinical features, and prognostic implications of cancer patients with cerebrovascular disease. Materials and Methods All patients with cerebrovascular disease (CVD)